PIK3CG and neoplasm: In other cancer types where PI3K pathway activation is not clonal such as in renal cell carcinoma, evidence indicates that the PI3K–AKT–mTORC1 pathway often becomes recurrently activated at multiple branch points during tumour evolution [152].